Pātea seabed mine: Caution as Taranaki councils called to declare positions on mine
Taranaki local body politicians are looking to keep their powder dry as the battle over seabed mining intensifies through the new fast-track process.
Pressure is mounting as the Environmental Protection Authority selects its panel to rule on an Australian company's bid to mine the South Taranaki seabed under the Fast-track
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Otago Daily Times
3 hours ago
- Otago Daily Times
Mill sale awaits Commerce Commission approval
The sale of a farmer-owned flour mill in South Canterbury's Washdyke must get Commerce Commission clearance to go ahead. The commission has received an application from George Weston Foods, trading as Mauri New Zealand, to buy the wheat milling and storage assets, including land, used by Farmers Mill. A purchase price was undisclosed with the sale subject to conditions including regulatory approval from the commission. The mill was opened at Washdyke in 2013 as New Zealand's only independent grower-owned and operated flour producer. Farmers Mill supplies bulk and bagged flour to industrial food manufacturers, bakeries, and some retailers. The mill is owned by Grainstor, South Island's largest grain storage facility. Directors for both companies are listed as Ashley Biggs, Raymond Bowan, Antony Howey and Murray Turley. A Commerce Commission spokeswoman said in a statement the commission could only give clearance to a proposed merger if it was satisfied it was unlikely to have the effect of substantially lessening competition in a market. Mauri operates flour mills in Auckland, Wellington and Christchurch, supplying flour in bulk to large users of flour such as industrial food manufacturers and bagged flour to wholesalers, bakeries and supermarkets. Mauri flour is also used by George Weston Foods' bakery division to produce breads and bakery goods under brands including Tip Top bread and Big Ben pies. Australian-based George Weston Foods is owned by Associated British Foods Plc, a company listed on the London Stock Exchange. Both Mauri and Farmers Mill also supply broll, which is a by-product of the wheat milling process and most commonly used as an input for animal feed. Farmers Mill bought its wheat milling plant from a company in Italy in 2012 for about $12 million. When the mill was launched the following year with former prime minister John Key cutting the ribbon, Mr Turley, as chairman, said South Canterbury arable farmers had teamed up to mill their own grain to gain more control of their grain production and create a homegrown product. "We have harnessed our own resources to secure the industry's future investing more than $10m to get Farmers Mill up and running," he said. Initially 12 local farmers were involved in the ground-up building of the mill. The commission expects to make a decision by early August.
Scoop
13 hours ago
- Scoop
St Vincent's Hospital Melbourne Signs Agreement With NZ MedTech Veriphi To Boost Medication Safety For Cancer Patients
Press Release – Veriphi The agreement marks the first commercial hospital contract for Veriphi, which has spent more than a decade developing an innovative analyser that uses laser spectrometry, AI and cloud computing to verify the identity and concentration of IV drugs in real … St Vincent's Hospital Melbourne has signed a 12-month supply agreement with New Zealand MedTech company Veriphi, to deploy its breakthrough intravenous medication verification technology in the hospital's sterile oncology compounding pharmacy. The agreement marks the first commercial hospital contract for Veriphi, which has spent more than a decade developing an innovative analyser that uses laser spectrometry, AI and cloud computing to verify the identity and concentration of IV drugs in real time. The goal: reduce preventable harm from medication errors and improve dosing accuracy for vulnerable cancer patients. St Vincent's Hospital Melbourne, a tertiary public healthcare provider with more than 880 beds and over 5,000 staff, is part of St Vincent's Health Australia – the country's largest not for-profit health and aged care provider. 'St Vincent's Hospital Melbourne is excited to be working with technology company Veriphi to improve medication safety in our sterile oncology compounding pharmacy,' said Andrew Cording, Chief Pharmacist from St Vincent's. 'The safety of our patients, including medication safety, is a top priority for St Vincent's, so we are proud to be working with world-leading technology.' The agreement reflects a shared commitment to innovation and safety in cancer care, with Veriphi's system designed to support pharmacists and clinical staff in verifying complex, high-risk medications. 'We are delighted to be working with St Vincent's Hospital Melbourne,' said Greg Shanahan, Managing Director of Veriphi. 'Our values regarding the protection of patient safety from medication error align perfectly with St Vincent's. We are proud to collaborate with an organisation whose culture and focus on patient outcomes are supported by Veriphi's breakthrough technology.' Medication errors remain one of the most serious – and preventable – threats to patient safety worldwide. Intravenous drugs, particularly those used in oncology, require precise handling and verification to avoid harm. Veriphi's analyser brings a new layer of safety, enabling hospitals to verify each dose at the point of compounding before administration to patients. The St Vincent's partnership marks a major milestone for Veriphi's commercial rollout, with further expansion plans underway across Australia, New Zealand, and the United States. Veriphi is currently raising funds to expand its impact around the globe. New Zealand and Australian residents can invest at
Scoop
16 hours ago
- Scoop
St Vincent's Hospital Melbourne Signs Agreement With NZ MedTech Veriphi To Boost Medication Safety For Cancer Patients
St Vincent's Hospital Melbourne has signed a 12-month supply agreement with New Zealand MedTech company Veriphi, to deploy its breakthrough intravenous medication verification technology in the hospital's sterile oncology compounding pharmacy. The agreement marks the first commercial hospital contract for Veriphi, which has spent more than a decade developing an innovative analyser that uses laser spectrometry, AI and cloud computing to verify the identity and concentration of IV drugs in real time. The goal: reduce preventable harm from medication errors and improve dosing accuracy for vulnerable cancer patients. St Vincent's Hospital Melbourne, a tertiary public healthcare provider with more than 880 beds and over 5,000 staff, is part of St Vincent's Health Australia – the country's largest not for-profit health and aged care provider. 'St Vincent's Hospital Melbourne is excited to be working with technology company Veriphi to improve medication safety in our sterile oncology compounding pharmacy,' said Andrew Cording, Chief Pharmacist from St Vincent's. 'The safety of our patients, including medication safety, is a top priority for St Vincent's, so we are proud to be working with world-leading technology.' The agreement reflects a shared commitment to innovation and safety in cancer care, with Veriphi's system designed to support pharmacists and clinical staff in verifying complex, high-risk medications. 'We are delighted to be working with St Vincent's Hospital Melbourne,' said Greg Shanahan, Managing Director of Veriphi. 'Our values regarding the protection of patient safety from medication error align perfectly with St Vincent's. We are proud to collaborate with an organisation whose culture and focus on patient outcomes are supported by Veriphi's breakthrough technology.' Medication errors remain one of the most serious – and preventable – threats to patient safety worldwide. Intravenous drugs, particularly those used in oncology, require precise handling and verification to avoid harm. Veriphi's analyser brings a new layer of safety, enabling hospitals to verify each dose at the point of compounding before administration to patients. The St Vincent's partnership marks a major milestone for Veriphi's commercial rollout, with further expansion plans underway across Australia, New Zealand, and the United States. Veriphi is currently raising funds to expand its impact around the globe. New Zealand and Australian residents can invest at
